RPS6 and mantle cell lymphoma: PF-04691502, a novel phosphoinositide 3-kinase (PI3K)/mTOR inhibitor has potent activity in MCL cell lines, and PF-04691502 decreased phosphorylation of Akt and S6 ribosomal protein.